Immunovia AB (publ) Corporate Call Transcript
Hello, and welcome to Immunovia press conference call. (Operator Instructions) Today, I am pleased to present Patrik Dahlen, CEO; Thomas King, MD, PhD; and Linda Mellby, PhD. Please begin your meeting.
()-
Thank you very much. Good afternoon, everyone, and thank you for joining us today. And thank you for your continued interest in Immunovia. My name is Patrik Dahlen. I'm the CEO of Immunovia. With me on this call are Thomas King, Dr. Thomas King, who is our Medical Director; and Dr. Linda Mellby, who is our Vice President of R&D. We will be presenting the data from the blinded validation study performed in our Dx Lab in Marlborough, Massachusetts. And we will be presenting the data from a test performance improvement study performed here in the R&D lab in Lund, Sweden.
On the next page, Page 2, please, you can read our disclaimers and our forward-looking statements, and I encourage you to read these at your leisure.
Next page, please, Page 3. Today's agenda is as
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
